Chemotherapy sounds the alarm
Greetings! My name is Pat Murphy, a postdoctoral fellow in the Departments of Pathology and Microbiology and Immunology at Dalhousie University in Dr. Shashi Gujar’s laboratory where we study cancer immunology and oncolytic (cancer-killing) viruses. I received funding support from the Breast Cancer Society of Canada and the QEII Foundation through the Beatrice Hunter Cancer […]
Targeting tumours the FAST way
Hello! We are Brent Johnston and Roy Duncan, Professors in the Department of Microbiology & Immunology at Dalhousie University. We have received funding from the Breast Cancer Society of Canada and the QEII Foundation through the Beatrice Hunter Cancer Research Institute, to investigate the use of viruses to target advanced and metastatic breast cancer. Oncolytic […]
Retinoic Acid maybe an effective therapy
I am Dr. Paola Marcato, Assistant Professor in the Department of Pathology at Dalhousie University. the Canadian Breast Cancer Society, the Beatrice Hunter Cancer Research Institute and the QEII Foundation, have funded my research lab and colleagues: Drs. Carman Giacomantonio, Lucy Helyer and Ian Weaver. Our research is to investigate if a vitamin A metabolite, retinoic […]
How do breast cancer cells move through the body?
Drs. Desnoyers and Lewis are working to understand how breast cancer cells can move throughout the body. Breast cancer becomes more aggressive when normal breast cells change to become invasive by a process called epithelial-to-mesenchymal transition (EMT). Following EMT, breast cancer cells can move throughout the body and spread the tumor, an event known as […]
Finding the best cancer medication for your budget
In a climate of escalating drug costs – when a month’s supply of cancer medication can run into thousands of dollars – it’s critical for decision makers to maximize health gains within current budget constraints. Indeed, in public health care systems, such as exists in Canada, funding decisions for new cancer drugs currently take into […]
